Rivaroxaban for treatment in venous thrombosis in children

Registry ID

EUCTR2011-004539-30

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Bayer AG

Start date

2012-10-23

Completion date

2016-09-01

Last update

2026-08-16

Conditions

• venous thrombosis

Summary

The primary objective is: • to assess the incidence of major bleeding and clinically relevant non-major bleeding

Locations

• , , Netherlands
• , , Germany
• , , Italy
• , , Austria

View on source registry